This Is MS Multiple Sclerosis Community: Knowledge & Support

Well maybe depends on your point of view - see other threads!

NICE's web site tells us this about this treatment.

My emphasis. Guess there'll be some jolly good data by then
I have emailled Dr Cumbers asking if there is any change given the FDA fasttrack approval. I'll post her reply here. http://www.nice.org.uk/page.aspx?o=207025

There is no current statement from UKMSSoc this one is from the Chief Executive Mike O’Donovan responding to the leaked stories earlier this month: I look forward to his statement saying that the Society will press for an immediate advancement of the NICE programme. There's a longer article but saying nothing new http://www.mssociety.org.uk/news_events/news/research/antegrenresults.html

A search of the European Medicines Agency's web site showed nothing for Tysabri nor Antegren nor Natalizumab. UKMSSoc suggest that it is this body that approves a drug for use in the EU (hence UK). Anyone know if this is so? http://www.emea.eu.int/

_________________
John
I am what I am

John,
2 months ago I spoke with a professor of clinical neuroscience about Antegren (Tysabri). I was told that as soon as FDA approval was granted, he would be able to prescribe in the UK. I guess that whether you will be able to get a prescription within the UK will depend upon the old postcode lottery until NICE comes up with a definitive statement.

I have another appointment with him in January. I will put the question to him directly at that time and try to get a complete answer.

Robin

It seems that once again burreocracy -and not MS- is the issue. I don't know if this has anything to do with a European drug makers' sales and their useles, ineffective, expensive and full-of-side-effects treatment. (Their advertising slogan should be: Imagine a side effect, we have it!)

Anyway, what are they waiting for? Are all these stupid meetings needed? I understand that they have responsibility about the safety of a new medicine, but, wait a minute! The same people gave their approval for Rebif! Who sane person would do such a thing! (Only one that does not have to take it, of course!). And what a patient may suffer by MS is far more than what Tysabri may cause. (but far far far less by what Rebif may cause!)

But it seems that nobody in EMEA has MS, so who cares? "Let Serono, doctors and wheelchair makers earn some more money and some day in the distant future, we will approve Tysabri. But first, we have to eliminate the People Front of Judea! Splitters!"